Sterling Pharma Solutions
Tracy O'Callaghan is an experienced professional in the pharmaceutical and medical device industries, currently serving as Project Team Lead at Sterling Pharma Solutions since January 2023. Prior to this role, O'Callaghan was the Production Unit Facilitator at Novartis from June 2017 to January 2023, overseeing a portfolio of products in a production unit, including the management of a multi-step new product introduction. Previously, O'Callaghan worked as a Senior Process Engineer at Hovione, focusing on product transfer and launch, as well as handling commercial products for third parties from June 2012 to October 2016. Additional experience includes roles as a Process Development Engineer at Boston Scientific, a Process Engineer at Pfizer, and a Process Engineer at Millipore Ireland BV, covering a span of nearly two decades in engineering and management positions within these organizations.
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities